Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Pediatric Subjects With Congenital Adrenal Hyperplasia

Condition:   CAH - Congenital Adrenal Hyperplasia Intervention:   Drug: NBI-74788 Sponsor:   Neurocrine Biosciences Recruiting

Source: ClinicalTrials.gov - August 5, 2019 Category: Research Source Type: clinical trials